Health Management Associates, Inc.

hma.com

Health Management Associates, Inc. (NYSE: HMA) is a premier operator of general acute care, non-urban hospitals located throughout the United States, primarily in the Southeast and Southwest. Health Management Associates, Inc. was founded in 1977 to own, lease and manage hospitals throughout the United States. In 1983, the company redirected its focus toward acquiring, improving and operating under-performing hospitals in attractive, non-urban areas. Since then, Health Management has become a leading niche operator of acute-care medical hospitals in the U.S.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

APPLIED DNA ANNOUNCES RECEIPT OF LARGEST SINGLE PURCHASE ORDER FOR LINEARDNA™ TO-DATE

Applied DNA Sciences | October 11, 2022

news image

Applied DNA Sciences, Inc. a leader in PCR-based DNA technologies, announced that it received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. The order was placed under a long-standing supply agreement for the bulk manufacture of LinearDNA for a global manufacturer of in vitro diagnostics. Under the terms of the repeat order, the Company will deliver quantities of LinearDNA to the customer in the current quarter, with the full order expected to be fulfill...

Read More

MedTech

SOLVIAS ACQUIRES CERGENTIS TO BOLSTER BIOLOGICS AND CELL & GENE THERAPY CAPABILITIES

Solvias | July 18, 2022

news image

Solvias, one of the world's leading independent pharmaceutical testing and manufacturing companies, announced today that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy testing solutions. According to pharmaceutical market intelligence provider, Evaluate, global sales of cell and gene therapies are projected to accelerate at a 63% compound annual growth rate through 2026. As more resear...

Read More

Medical

EMMAUS LIFE SCIENCES ANNOUNCES LAUNCH OF FULL-SERVICE TELEHEALTH SOLUTION

Emmaus Life Sciences, Inc. | April 12, 2022

news image

Emmaus Life Sciences, Inc. (OTQXC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced the launch of an innovative full-service telehealth solution with its strategic partners, including Asembia LLC, US Bioservices Corporation and UpScriptHealth. The telehealth program capitalizes on the expansion of telemedicine in the U.S. to afford patients and providers on-line access to Endari®, the company's prescription-grade L-gl...

Read More

Medical

ACROBAT GENOMICS, NANOSTRING, AND ILLUMINA ACCELERATOR COLLABORATE WITH STANFORD MEDICINE TO DISCOVER NEW DRUG TARGETS

Businesswire | June 09, 2023

news image

Acrobat Genomics, NanoString Technologies, Inc. and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis. NanoString’s GeoMx DSP is a powerful spatial biology platform that ...

Read More
news image

Industrial Impact

APPLIED DNA ANNOUNCES RECEIPT OF LARGEST SINGLE PURCHASE ORDER FOR LINEARDNA™ TO-DATE

Applied DNA Sciences | October 11, 2022

Applied DNA Sciences, Inc. a leader in PCR-based DNA technologies, announced that it received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. The order was placed under a long-standing supply agreement for the bulk manufacture of LinearDNA for a global manufacturer of in vitro diagnostics. Under the terms of the repeat order, the Company will deliver quantities of LinearDNA to the customer in the current quarter, with the full order expected to be fulfill...

Read More
news image

MedTech

SOLVIAS ACQUIRES CERGENTIS TO BOLSTER BIOLOGICS AND CELL & GENE THERAPY CAPABILITIES

Solvias | July 18, 2022

Solvias, one of the world's leading independent pharmaceutical testing and manufacturing companies, announced today that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy testing solutions. According to pharmaceutical market intelligence provider, Evaluate, global sales of cell and gene therapies are projected to accelerate at a 63% compound annual growth rate through 2026. As more resear...

Read More
news image

Medical

EMMAUS LIFE SCIENCES ANNOUNCES LAUNCH OF FULL-SERVICE TELEHEALTH SOLUTION

Emmaus Life Sciences, Inc. | April 12, 2022

Emmaus Life Sciences, Inc. (OTQXC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced the launch of an innovative full-service telehealth solution with its strategic partners, including Asembia LLC, US Bioservices Corporation and UpScriptHealth. The telehealth program capitalizes on the expansion of telemedicine in the U.S. to afford patients and providers on-line access to Endari®, the company's prescription-grade L-gl...

Read More
news image

Medical

ACROBAT GENOMICS, NANOSTRING, AND ILLUMINA ACCELERATOR COLLABORATE WITH STANFORD MEDICINE TO DISCOVER NEW DRUG TARGETS

Businesswire | June 09, 2023

Acrobat Genomics, NanoString Technologies, Inc. and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis. NanoString’s GeoMx DSP is a powerful spatial biology platform that ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us